Morgan L. McLemore, MD
-
RoleHematology Oncology
-
Specialty
-
Research Program
-
Practicing Since2001
Rating: 4.8 out of 5 (107 ratings)
Title/Journal | Authors | Publication Date |
---|---|---|
AJPM focus |
BK Attell, PM Barrett, BS Pace, ML McLemore, BT McGee, R Oshe, AM DiGirolamo, LL Cohen, AB Snyder | 01/02/2024 |
Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity. Annals of diagnostic pathology |
T Javadi, C Hill, ML McLemore, S Oskouei, A Bahrami | 01/10/2023 |
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease. British journal of haematology |
H Nakahara, N Cheedarla, HP Verkerke, S Cheedarla, SC Wu, JE Hendrickson, A Chang, ML McLemore, F El Rassi, JD Roback, AS Neish, RM Fasano, SR Stowell | 01/09/2023 |
JMIR public health and surveillance |
A Singh, MK Sontag, M Zhou, M Dasgupta, T Crume, M McLemore, N Galadanci, E Randall, N Steiner, AM Brandow, K Koch, JJ Field, K Hassell, AB Snyder, J Kanter | 28/06/2023 |
Expert review of hematology |
K Clarke, YM Shin, MAK Hall, M Moussa, M McLemore, F El Rassi | 01/02/2023 |
Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. Journal of investigative medicine high impact case reports |
K Clarke, K Benameur, Z Wiley, YM Shin, M Moussa, F El Rassi, M McLemore | 01/01/2022 |
JCO oncology practice |
AP Jillella, ML Arellano, M Gaddh, AA Langston, LT Heffner, EF Winton, ML McLemore, C Zhang, CR Caprara, KS Simon, SL Bolds, S DeBragga, P Karkhanis, SH Krishnamurthy, J Tongol, MM El Geneidy, A Pati, JM Gerber, MR Grunwald, J Cortes, A Bashey, RK Stuart, VK Kota | 01/04/2021 |
Blood cells, molecules & diseases |
O Niss, RB Lorsbach, M Berger, S Chonat, M McLemore, D Buchbinder, T McCavit, LG Shaffer, J Simpson, JH Schwartz, J Meznarich, M Emberesh, KG Seu, W Zhang, TA Kalfa | 01/03/2021 |
Transfusion |
CL Dean, CL Maier, S Chonat, A Chang, MA Carden, F El Rassi, ML McLemore, SR Stowell, RM Fasano | 01/05/2019 |
Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease. World journal of hepatology |
JP Haydek, C Taborda, R Shah, PA Reshamwala, ML McLemore, FE Rassi, S Chawla | 27/03/2019 |
British journal of haematology |
S Chonat, ML McLemore, ST Bunting, S Nortman, K Zhang, TA Kalfa | 01/07/2018 |
Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure. Transfusion |
CL Maier, PJ Gross, CL Dean, S Chonat, A Ip, M McLemore, F El Rassi, SR Stowell, CD Josephson, RM Fasano | 01/06/2018 |
Clinical lymphoma, myeloma & leukemia |
VK Kota, JH Kong, M Arellano, F El Rassi, M Gaddh, LT Heffner, EF Winton, AP Jillella, ML McLemore, HJ Khoury | 01/12/2017 |
A 49-Year-Old Man With Cirrhosis and Pulmonary Fibrosis. Chest |
P Rajaram, B Little, JP Norvell, M McLemore, S Veeraraghavan | 01/02/2016 |
Leukemia & lymphoma |
Z Mitri, MT Siddiqui, F El Rassi, JT Holden, LT Heffner, A Langston, EK Waller, E Winton, M McLemore, L Bernal-Mizrachi, D Jaye, M Arellano, HJ Khoury | 01/07/2014 |
Genistein protects hematopoietic stem cells against G-CSF-induced DNA damage. Cancer prevention research (Philadelphia, Pa.) |
LR Souza, E Silva, E Calloway, O Kucuk, M Rossi, ML McLemore | 01/05/2014 |
Cancer |
AG Antun, S Gleason, M Arellano, AA Langston, ML McLemore, M Gaddh, F el Rassi, L Bernal-Mizrachi, J Galipeau, LT Heffner, EF Winton, HJ Khoury | 01/11/2013 |
G-CSF activation of AKT is not sufficient to prolong neutrophil survival. Journal of leukocyte biology |
LR Souza, E Silva, E Calloway, C Cabrera, ML McLemore | 01/06/2013 |
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. British journal of haematology |
D Muringampurath-John, DL Jaye, CR Flowers, D Saxe, Z Chen, MJ Lechowicz, DD Weisenburger, M Bast, ML Arellano, L Bernal-Mizrachi, LT Heffner, M McLemore, JL Kaufman, EF Winton, S Lonial, JO Armitage, HJ Khoury | 01/09/2012 |
Managing chronic myeloid leukemia: a coordinated team care perspective. Clinical lymphoma, myeloma & leukemia |
S Holloway, K Lord, B Bethelmie-Bryan, MW Shepard, J Neely, M McLemore, SK Reddy, A Montero, WS Jonas, SP Gladney, SL Khanwani, SC Reddy, AK Lahiry, LT Heffner, E Winton, M Arellano, HJ Khoury | 01/04/2012 |
Leukemia & lymphoma |
D Muringampurath-John, CR Flowers, M Toscano, C Zhengjia, JL Kaufman, M Arellano, L Bernal-Mizrachi, LT Heffner, MJ Lechowicz, M McLemore, E Winton, DL Jaye, S Lonial, HJ Khoury | 01/04/2012 |
Cancer |
M Arellano, E Winton, L Pan, L Lima, M Tighiouart, K Bhalla, LT Heffner, J Neely, D Hutcherson, M McLemore, A Langston, HJ Khoury | 15/01/2012 |
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia |
M Arellano, L Bernal-Mizrachi, L Pan, M Tighiouart, L Souza, X Guo, M McLemore, L Lima, S Sunay, LT Heffner, Z Chen, GZ Chen, A Langston, E Winton, HJ Khoury | 01/10/2011 |
Leukemia & lymphoma |
LM Lima, K Sampat, S Assouline, D Saxe, S Nault, M Tighiouart, M McLemore, M Arellano, E Winton, L Bernal-Mizrachi, J Cortes, HJ Khoury | 01/06/2011 |
Cancer |
L Lima, L Bernal-Mizrachi, D Saxe, KP Mann, M Tighiouart, M Arellano, L Heffner, M McLemore, A Langston, E Winton, HJ Khoury | 15/03/2011 |
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.8 |
| Provider showed concern |
4.8 |
| Provider explained things clearly |
4.8 |
| Provider discussed treatment options |
4.8 |
| Provider included you in decisions |
4.8 |
| Likelihood of recommending this provider |
|
08/05/2024 |
Very good |
|
27/03/2024 |
Most definitely |
|
07/02/2024 |
Top notch interaction! |
|
01/12/2023 |
I thought Dr.McLemore wS just wondetful;very frank and to the point,very informative,very encouraging,very kind and understanding. |
|
29/11/2023 |
I would recommend Dr Macklemore to anyone |
|
05/10/2023 |
Most information received was a result of answers to questions. Not clear if doctor understands the terror of the diagnosis. |
|
27/09/2023 |
I'm very comfortable having Dr McLemore care for me. |
|
30/08/2023 |
Dr McLemore is a great doctor. I will follow his advice. |
|
09/08/2023 |
Dr McLemore is excellent and the fellow was superb as well. |
|
02/08/2023 |
So glad I came here |
|
02/08/2023 |
Dr McLemore is an outstanding physician. |
|
12/07/2023 |
My concerns were addressed. |
|
28/06/2023 |
Dr. McLemore was thorough and completely engaged. First rate. |
|
24/06/2023 |
Very nice doctor |
|
11/04/2023 |
Very pleased with attention given to me and discussions regarding my concerns. All of these were addressed. |
|
23/03/2023 |
Doctors are very knowledgeable and seem very determined to help you resolve health issues! |
|
14/09/2022 |
Dr McLemore was very thorough in explaining the diagnosis and prognosis of the disease. He came very highly recommended by my oncologist |
|
24/08/2022 |
Very pleased |
|
17/08/2022 |
Dr McElmore was very patient and listened to my concerns. He gave me a lot of information and answered all my questions. I felt he was genuinely concerned. Great bedside manner. |
|
10/08/2022 |
The best interaction with a doctor that I've ever had. He was very thorough in explaning how tests were performed, percentages and how to interpret results. |
|
10/08/2022 |
Dr McLemore was very thorough, knowledgeable and put me at ease about condition and treatment. |
|
10/08/2022 |
Dr. Mclemore decided before he ever stepped into the room to meet with me that my only problem was being overweight. He didn't ask me any other symptoms or issues I may have. He didn't attempt to rule out or assuage any other concerns about what else may cause inflammation. He offered no further advice or what to look for going forward and he was dismissive of anything else other than deciding I was overweight and that was it. I've never felt so humiliated and dismissed by a doctor before. Had someone come to him with my same exact issues, but had not been overweight, I have to wonder if he'd have been more concerned then. Would he have prompted them with any other causes of inflammation? Would he have offered or suggested further tests to narrow down where the inflammation may be? Would he have taken the concern seriously? Because he decided the second he saw my weight that he wasn't concerned about a thing and he wasn't going to be swayed otherwise. I left his office in tears, feeling incredibly dehumanized. |
|
25/05/2022 |
Appointment very rushed, complete blood work not available, did not receive print out of visit as I normally get |